High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
about
Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker.Preventing coronary artery lesions in Kawasaki disease.Acetylsalicylic acid for children with Kawasaki disease.L’acide acétylsalicylique pour les enfants atteints de la maladie de Kawasaki.Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease.Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease.Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.Is aspirin necessary in the acute phase of Kawasaki disease?Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease.Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease.Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
P2860
Q36104063-E54BCB7D-80A9-4672-8993-E192C093341AQ37206453-656F1F1B-E3E7-492C-BAC1-353BAB354995Q39247857-FCA24550-C607-41E7-B73F-563399E4E8DDQ39399053-FB2BEEDA-99FA-4743-80D6-EAE30963E801Q40043358-7361E1F3-8EAC-4CD1-A6DA-F5B403526B99Q41379432-D7E118E0-6C40-4A42-A433-06862EB59E77Q41613086-D15910F5-00F2-4266-903F-7DA76CD35562Q41863276-A0BC3015-1C7A-4321-A007-CA8E246C5B66Q42010551-926744F2-EE75-4A15-B997-55217483A0DEQ42759549-B4AC922A-F160-4552-A0B9-9639699DC3D1Q47261379-58598AA5-7124-434B-9D21-C7B7BA076861Q54248487-4B8EC641-99B7-4937-9CA4-E9286E8CBC78Q54945663-9E56CDA2-B317-4A97-BD39-B1804BD78BE1Q55280563-068917F8-C7B8-428C-A2B5-74DF64B379EAQ55446513-6F4261F4-3564-4DA9-A528-5F4BE20DFD29
P2860
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@ast
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@en
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@nl
type
label
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@ast
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@en
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@nl
prefLabel
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@ast
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@en
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@nl
P2093
P2860
P3181
P1433
P1476
High-Dose Aspirin is Associate ...... e Outcomes in Kawasaki Disease
@en
P2093
Mao-Hung Lo
Mindy Ming-Huey Guo
Ying-Hsien Huang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0144603
P407
P577
2015-01-01T00:00:00Z